Track topics on Twitter Track topics that are important to you
MILWAUKEE, July 26, 2018 /PRNewswire/ -- Mortgage Guaranty Insurance Corporation (MGIC) (NYSE: MTG) announced that Michael E. Jacobson joined the company on July 16, 2018 Read more...
"Paul, Paul, slow down. I've spent my whole lifetime studying the brain, and not in my lifetime, and probably not in your lifetime will we understand how the brain works."
LONDON (dpa-AFX) - Vectura Group plc (VEC.L) said that it appointed Paul Fry as Chief Financial Officer and Executive Director with effect from 29 October 2018. Paul succeeds Andrew Derodra who, a...
Steve Paul has been appointed CEO of US biotech Karuna, to lead development of the psychiatric drug xanomeline, a previously shelved project that he helped to develop at Eli Lilly in the 1990s. Paul ...
Former Voyager Therapeutics (NASDAQ: VYGR) CEO Steven Paul has been tapped to run Boston-based Karuna Pharmaceuticals, a PureTech Health company that just raised $42 million this month. Karuna is deve...
In this episode of PharmaTelevision News Review, Fintan Walton talks with Ken MacLeod, Partner at Paul Capital Partners. Filmed at BioTrinity 2010 in Newbury, UK.
In this episode of PharmaTelevision News Review, Fintan Walton talks to Paul Anderson, Managing Director of OrthoCell.
(American College of Surgeons) International award recognizes cancer researcher's role in developing effective immunotherapies and gene therapies for patients with advanced cancers.
3M™ Skin and Nasal Antiseptic(Povidone-Iodine Solution 5% w/w (0.5% available iodine) USP)
Nexcare™ Cold Sore Treatment
Avagard D Instant Hand Antiseptic with Moisturizers
to exemplify the applicability of the Jacobson and Truax Method in a nursing intervention study that analyzed the effectiveness of a home care teaching program after radical prostatectomy.
Three-dimensional (3D) perovskite materials display remarkable potential in photovoltaics owing to their superior solar-to-electric power conversion efficiency, with current efforts focused on improvi...
Temporomandibular joint disorders are ranked third among the most common stomatological diseases after dental caries and periodontal problems. Type of dysfunction is determined by environm...
This study looks at the difference in surgical scar outcomes between two different surgical incision methods during thyroid surgery: scalpel vs electrocautery. Patients who are already sch...
Randomized trial to proof the effects and efficacy of a new mindfulness and acceptance based group-treatment for depressive patients
The purpose of this study is to evaluate the effectiveness of the GI clinic's currently used web-based instructions at St. Paul's Hospital.
The purpose of this study is to determine if low level magnetic fields may help to relieve symptoms of Parkinson's disease.
The Jacobson Group is the leading global provider of insurance talent. For more than 40 years, we have been connecting insurance organizations with professionals from the board ro...
Through its funds, Paul Capital Healthcare is one of the largest dedicated healthcare investors globally, with more than $1.6 billion in equity capital commitments and debt facilities under management...
The Paul-Ehrlich-Institut was founded on 1st June 1896 as Institut für Serumforschung und Serumprüfung (Institute for Serum Research and Serum Testing) at Steglitz near Berlin as a test and research...
We have published hundreds of Paul “Dr. J” Jacobson, M.D. news stories on BioPortfolio along with dozens of Paul “Dr. J” Jacobson, M.D. Clinical Trials and PubMed Articles about Paul “Dr. J” Jacobson, M.D. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Paul “Dr. J” Jacobson, M.D. Companies in our database. You can also find out about relevant Paul “Dr. J” Jacobson, M.D. Drugs and Medications on this site too.